Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.98)
# 3,612
Out of 4,732 analysts
472
Total ratings
25.47%
Success rate
-18.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Maintains: Buy | $17 → $14 | $8.03 | +74.35% | 10 | Jan 14, 2025 | |
| RLAY Relay Therapeutics | Reiterates: Buy | $16 | $4.46 | +258.74% | 20 | Jan 14, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $21 | $9.58 | +119.21% | 18 | Jan 13, 2025 | |
| YMAB Y-mAbs Therapeutics | Reiterates: Buy | $22 | $6.16 | +257.14% | 19 | Jan 13, 2025 | |
| EXEL Exelixis | Maintains: Buy | $29 → $40 | $36.20 | +10.50% | 4 | Jan 10, 2025 | |
| NUVB Nuvation Bio | Reiterates: Buy | $7 | $2.51 | +178.88% | 12 | Jan 6, 2025 | |
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $2.04 | +243.14% | 6 | Jan 6, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $8 | $1.83 | +337.16% | 20 | Jan 6, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $30 → $35 | $19.14 | +82.86% | 13 | Dec 11, 2024 | |
| BCAX Bicara Therapeutics | Initiates: Buy | $42 | $12.11 | +246.82% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $72 | $40.29 | +78.70% | 18 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $10.14 | +67.65% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $12 | $13.88 | -13.54% | 19 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $111.93 | +34.01% | 37 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $24.41 | +47.48% | 6 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $12.39 | +166.34% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.53 | +488.24% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $74 | $34.63 | +113.69% | 28 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.79 | +590.85% | 2 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $2.85 | +356.14% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.82 | +394.51% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.05 | +376.19% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.28 | +681.25% | 17 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.00 | +33.33% | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.20 | +400.00% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $21.47 | +72.33% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.77 | +521.47% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.25 | +60.00% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.98 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.57 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.37 | +264.96% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.99 | +127.14% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.55 | +2,085.79% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $9.56 | +1,992.05% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.17 | +2,268.27% | 8 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.89 | +2,137.39% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.10 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.39 | +6,176.15% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.50 | +1,366.67% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.27 | +451.18% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $0.84 | +1,209.52% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $1.14 | +19,636.84% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $5.56 | +350.05% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $2.22 | +485.59% | 1 | Jan 7, 2021 |
Cogent Biosciences
Jan 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $8.03
Upside: +74.35%
Relay Therapeutics
Jan 14, 2025
Reiterates: Buy
Price Target: $16
Current: $4.46
Upside: +258.74%
ORIC Pharmaceuticals
Jan 13, 2025
Reiterates: Buy
Price Target: $21
Current: $9.58
Upside: +119.21%
Y-mAbs Therapeutics
Jan 13, 2025
Reiterates: Buy
Price Target: $22
Current: $6.16
Upside: +257.14%
Exelixis
Jan 10, 2025
Maintains: Buy
Price Target: $29 → $40
Current: $36.20
Upside: +10.50%
Nuvation Bio
Jan 6, 2025
Reiterates: Buy
Price Target: $7
Current: $2.51
Upside: +178.88%
Immix Biopharma
Jan 6, 2025
Reiterates: Buy
Price Target: $7
Current: $2.04
Upside: +243.14%
ADC Therapeutics
Jan 6, 2025
Reiterates: Buy
Price Target: $8
Current: $1.83
Upside: +337.16%
Nurix Therapeutics
Dec 11, 2024
Maintains: Buy
Price Target: $30 → $35
Current: $19.14
Upside: +82.86%
Bicara Therapeutics
Dec 6, 2024
Initiates: Buy
Price Target: $42
Current: $12.11
Upside: +246.82%
Dec 4, 2024
Maintains: Buy
Price Target: $64 → $72
Current: $40.29
Upside: +78.70%
Nov 22, 2024
Reiterates: Buy
Price Target: $17
Current: $10.14
Upside: +67.65%
Nov 22, 2024
Reiterates: Neutral
Price Target: $12
Current: $13.88
Upside: -13.54%
Nov 18, 2024
Reiterates: Buy
Price Target: $150
Current: $111.93
Upside: +34.01%
Nov 15, 2024
Reiterates: Buy
Price Target: $36
Current: $24.41
Upside: +47.48%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $12.39
Upside: +166.34%
Nov 15, 2024
Reiterates: Buy
Price Target: $9
Current: $1.53
Upside: +488.24%
Nov 12, 2024
Maintains: Buy
Price Target: $76 → $74
Current: $34.63
Upside: +113.69%
Nov 8, 2024
Reiterates: Buy
Price Target: $40
Current: $5.79
Upside: +590.85%
Nov 8, 2024
Reiterates: Buy
Price Target: $13
Current: $2.85
Upside: +356.14%
Nov 8, 2024
Reiterates: Buy
Price Target: $9
Current: $1.82
Upside: +394.51%
Nov 8, 2024
Reiterates: Buy
Price Target: $5
Current: $1.05
Upside: +376.19%
Nov 8, 2024
Reiterates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Nov 6, 2024
Reiterates: Neutral
Price Target: $4
Current: $3.00
Upside: +33.33%
Nov 6, 2024
Reiterates: Buy
Price Target: $11
Current: $2.20
Upside: +400.00%
Oct 1, 2024
Reiterates: Buy
Price Target: $37
Current: $21.47
Upside: +72.33%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.77
Upside: +521.47%
Aug 23, 2024
Reiterates: Buy
Price Target: $10
Current: $6.25
Upside: +60.00%
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.98
Upside: -
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $6.57
Upside: -
Aug 20, 2024
Reiterates: Buy
Price Target: $5
Current: $1.37
Upside: +264.96%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.99
Upside: +127.14%
Aug 15, 2024
Reiterates: Buy
Price Target: $12
Current: $0.55
Upside: +2,085.79%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $9.56
Upside: +1,992.05%
Apr 16, 2024
Reiterates: Buy
Price Target: $4
Current: $0.17
Upside: +2,268.27%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.89
Upside: +2,137.39%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.10
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.39
Upside: +6,176.15%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.50
Upside: +1,366.67%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.27
Upside: +451.18%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $0.84
Upside: +1,209.52%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $1.14
Upside: +19,636.84%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $5.56
Upside: +350.05%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $2.22
Upside: +485.59%